At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Folic Acid +1 moredrug
Likely dose
Folic Acid 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children: a Randomized Double Blinded Placebo Controlled Trial
Queen Sirikit National Institute of Child Health·interventional·Posted Jan 11, 2013·Updated Dec 11, 2015
In Brief
A Phase 4 clinical trial evaluating Folic Acid and placebo for Hyperhomocysteinemia and Obesity. Completed, enrolled 50 participants across 2 sites.
Detailed Summary
The purpose of the present study was to determine whether folic acid supplementation could reduce plasma homocysteine in obese children and to determine the association between dietary folate, serum folate and homocysteine level through the randomized double blinded placebo controlled trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperhomocysteinemia, Obesity
CountriesThailand
CollaboratorsChulalongkorn University
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
First PostedJan 2013
Primary CompletionMar 2013
TodayJul 2026
First PostedJan 11, 2013
Enrollment StartDec 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.5 years ago
Interventions
Folic Aciddrug
yellow tablet contained 5mg of folic acid, manufactured from the Government Pharmaceutical Organization, Ministry of Public Health, Thailand
placebodrug
sugar tablet manufactured to mimic folic acid tablet